ArticleMalaria journal2025
Pyrethroid susceptibility and resistance patterns in Anopheles gambiae populations from Rwanda.
Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Malaria transmission dynamics, vector diversity, and insecticide resistance profiles in two health districts of southern Benin.BMC infectious diseases · 2026Article
- Molecular surveillance of Falciparum malaria in Rwanda: Shifts in parasite prevalence and risk factors between the 2014-15 and 2019-20 Rwanda Demographics and Health Surveys.medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence-based vector control interventions depend on understanding the distribution and mechanisms of insecticide resistance in malaria vectors. This study assessed the status of insecticide resistance in Anopheles gambiae sensu lato (s.l.) to pyrethroids, permethrin, deltamethrin, and alphacypermethrin across 18 sites in 15 districts of Rwanda, representing key malaria transmission strata.
methodsLarvae were collected from October 2022 to April 2023 using the dipping method, reared to adulthood, and tested using WHO standard bioassays. Susceptibility profiles were analysed with chi-square tests to compare mortality rates.
resultsThere was a high resistance to permethrin in various sites, such as Gashora (42%), Mubuga (48%), Rwaza (69%), and Kirarambogo (70%). Pre-exposure to piperonyl butoxide (PBO) only partially restored susceptibility, with mortality between 70 and 80% at resistant sites. In Kigali city, mortality with alphacypermethrin was 94%, and with PBO, it failed to restore susceptibility, suggesting non-metabolic resistance was involved. Overall, the evidence indicates that metabolic mechanisms play a major role in pyrethroid resistance, though target-site mutations, such as kdr, cannot be ruled out. The reliance on phenotypic data without molecular confirmation remains a limitation, underscoring the need for molecular assays to identify resistance-associated genetic markers.
conclusionsThis study provides essential baseline data on the resistance status of An. gambiae s.l. in Rwanda and highlights the urgent need to integrate molecular tools into routine surveillance to guide more effective vector control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.